Trial Condition(s):

Heart Failure

Chronic Heart Failure Burden of illness and Treatment Patterns

Bayer Identifier:

18428

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

The study aims to address questions related to the current burden of illness, treatment patterns and unmet needs in a contemporary heart failure population.The primary objective of the study is to better understand the patient characteristics, treatment patterns, and clinical outcomes of HF patients with preserved ejection fraction (>45%) [HFpEF] and HF patients with reduced ejection fraction (=>45%) [HFrEF] patients.

Inclusion Criteria
-  Adult patients who have been diagnosed with Heart Failure in a routine clinical practice database in the United States of America.
Exclusion Criteria
-  Patients who did not have any medical record in the system more than 30 days prior to their first heart failure diagnosis.

Trial Summary

Enrollment Goal
336000
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Unspecified
Accepts Healthy Volunteers
No

Where to Participate

Locations
Status
LocationsStatus

Trial Design